DK0617616T3 - Potensering af NMDA-antagonister - Google Patents
Potensering af NMDA-antagonisterInfo
- Publication number
- DK0617616T3 DK0617616T3 DK92925469T DK92925469T DK0617616T3 DK 0617616 T3 DK0617616 T3 DK 0617616T3 DK 92925469 T DK92925469 T DK 92925469T DK 92925469 T DK92925469 T DK 92925469T DK 0617616 T3 DK0617616 T3 DK 0617616T3
- Authority
- DK
- Denmark
- Prior art keywords
- potentiation
- nmda antagonists
- antagonists
- nmda
- poteniating
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/811,204 US5318985A (en) | 1991-12-20 | 1991-12-20 | Potentiation of NMDA antagonists |
| PCT/US1992/010354 WO1993012780A1 (en) | 1991-12-20 | 1992-12-01 | Potentiation of nmda antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0617616T3 true DK0617616T3 (da) | 2000-04-17 |
Family
ID=25205874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92925469T DK0617616T3 (da) | 1991-12-20 | 1992-12-01 | Potensering af NMDA-antagonister |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5318985A (da) |
| EP (1) | EP0617616B1 (da) |
| JP (1) | JPH07504890A (da) |
| AT (1) | ATE185969T1 (da) |
| AU (1) | AU667333B2 (da) |
| CA (1) | CA2124799A1 (da) |
| DE (1) | DE69230224T2 (da) |
| DK (1) | DK0617616T3 (da) |
| NZ (1) | NZ246114A (da) |
| WO (1) | WO1993012780A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5189054A (en) * | 1990-11-02 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | 3-amidoindolyl derivatives and pharmaceutical compositions thereof |
| GB9716657D0 (en) | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
| GB9803226D0 (en) | 1998-02-17 | 1998-04-08 | Zeneca Ltd | Chemical compounds |
| GB9902455D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902461D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902453D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902452D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902459D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB0000625D0 (en) | 2000-01-13 | 2000-03-01 | Zeneca Ltd | Chemical compounds |
| US7375136B2 (en) * | 2001-03-08 | 2008-05-20 | Emory University | pH-dependent NMDA receptor antagonists |
| EA201070077A1 (ru) * | 2007-06-29 | 2010-08-30 | Эмори Юниверсити | Антагонисты nmda-рецепторов с нейропротективным действием |
| EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2608507A (en) * | 1949-08-20 | 1952-08-26 | Sharp & Dohme Inc | Dialkyl sulfamyl benzoic acids |
| US2608508A (en) * | 1949-08-20 | 1952-08-26 | Sharp & Dohme Inc | N-amylsulfamyl benzoic acids |
| JPS5756425A (en) * | 1980-09-20 | 1982-04-05 | Santen Pharmaceut Co Ltd | Hypotensor |
| US4960786A (en) * | 1989-04-24 | 1990-10-02 | Merrell Dow Pharmaceuticals Inc. | Excitatory amino acid antagonists |
| US5095009A (en) * | 1990-04-11 | 1992-03-10 | Merrell Dow Pharmaceuticals Inc. | NMDA antagonists |
| US5051442A (en) * | 1990-04-25 | 1991-09-24 | Merrell Dow Pharmaceuticals Inc. | 3-indolyl thioacetate derivatives and NMDA receptor antagonistic use thereof |
| DE4021545A1 (de) * | 1990-07-06 | 1992-01-16 | Engineering Der Voest Alpine I | Verfahren und vorrichtung zum herstellen von kunststoffaeden oder -fasern aus polymeren, insbesondere polyamid, polyester oder polypropylen |
| KR0178469B1 (ko) * | 1990-07-16 | 1999-03-20 | 메이나드 알. 존슨 | 흥분성 아미노산 길항제 |
| JP3465794B2 (ja) * | 1991-02-27 | 2003-11-10 | メレルファーマスーティカルズ インコーポレイテッド | Ｎｍｄａ拮抗剤 |
| DK0501378T3 (da) * | 1991-02-28 | 1995-03-20 | Merrell Dow Pharma | NMDA-antagonister |
| CA2115442C (en) * | 1991-09-09 | 2003-09-23 | Christopher Franklin Bigge | Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist |
-
1991
- 1991-12-20 US US07/811,204 patent/US5318985A/en not_active Expired - Fee Related
-
1992
- 1992-12-01 EP EP92925469A patent/EP0617616B1/en not_active Expired - Lifetime
- 1992-12-01 WO PCT/US1992/010354 patent/WO1993012780A1/en not_active Ceased
- 1992-12-01 NZ NZ246114A patent/NZ246114A/en unknown
- 1992-12-01 JP JP5511664A patent/JPH07504890A/ja active Pending
- 1992-12-01 DE DE69230224T patent/DE69230224T2/de not_active Expired - Fee Related
- 1992-12-01 AT AT92925469T patent/ATE185969T1/de not_active IP Right Cessation
- 1992-12-01 CA CA002124799A patent/CA2124799A1/en not_active Abandoned
- 1992-12-01 DK DK92925469T patent/DK0617616T3/da active
- 1992-12-01 AU AU31509/93A patent/AU667333B2/en not_active Ceased
-
1994
- 1994-02-04 US US08/191,996 patent/US5489579A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2124799A1 (en) | 1993-07-08 |
| AU3150993A (en) | 1993-07-28 |
| JPH07504890A (ja) | 1995-06-01 |
| DE69230224T2 (de) | 2000-04-13 |
| EP0617616B1 (en) | 1999-10-27 |
| EP0617616A1 (en) | 1994-10-05 |
| NZ246114A (en) | 1995-10-26 |
| US5318985A (en) | 1994-06-07 |
| US5489579A (en) | 1996-02-06 |
| WO1993012780A1 (en) | 1993-07-08 |
| DE69230224D1 (de) | 1999-12-02 |
| ATE185969T1 (de) | 1999-11-15 |
| AU667333B2 (en) | 1996-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR038434A2 (es) | Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina | |
| DK93892D0 (da) | Fremgangsmaade til fremstilling af et depotpraeparat | |
| YU25497A (sh) | Postupak za dobijanje sildenafila | |
| DK0617616T3 (da) | Potensering af NMDA-antagonister | |
| ES2194003T3 (es) | Huperzina a racemica. | |
| FI914187L (fi) | Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta | |
| NO930035L (no) | Eksitatoriske aminosyreantagonister | |
| DK0535900T3 (da) | Ettrinsfremgangsmåde til fremstilling af dirithromycin | |
| DK23790A (da) | Doseringsform til administrering af en calciumantagonist | |
| CZ282732B6 (cs) | Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv | |
| DK0526478T3 (da) | 3-Indolyl-thioacetat-derivater | |
| FI920880A7 (fi) | NMDA-antagonisteja | |
| NO924361L (no) | Formazan parasittiske midler | |
| ATE137225T1 (de) | Dihydrochinolin nmda antagonisten | |
| FI973235A0 (fi) | Menetelmä IL-6:n vaikutusten inhiboimiseksi | |
| GR1001566B (el) | Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης. | |
| DK0457324T3 (da) | Heterocycliske NMDA antagonister | |
| FI940338L (fi) | Menetelmä 13alfa-sinnamoyylibakkatiini III:n tai -10-desasetyylibakkatiini III:n valmistamiseksi | |
| SE9102571D0 (sv) | A novel method of generating clones for the expression of unfused proteins | |
| FI922096A7 (fi) | Tetrahydro-5-substituoitu-3-metyleeni-2-furaanimetanolien stereo- ja enantioselektiivinen synteesi | |
| FI942248A7 (fi) | N-trityyliasparagiinihapon johdannaiset fosfonaatti-NMDA-antagonistien valmistamiseksi | |
| MX9205607A (es) | Procedimiento para la preparacion de: griseofulvina | |
| GR1001368B (el) | Φαρμακευτικοί φορείς. | |
| NO930438D0 (no) | Demonterbar laas | |
| ITRM910239V0 (it) | Protesi fonetica per laringectomizzati |